Zobrazeno 1 - 10
of 60
pro vyhledávání: '"A. Vezzelli"'
Autor:
Vezzelli, A., Verzè, S., Morbioli, L., Solazzo, L., Greco, A., Benetti, C., Cenacchi, V., Breda, M.
Publikováno v:
In Journal of Chromatography B 1 May 2023 1222
Autor:
Mameli, M., Franchi, J., Calusi, G., Deken, M.A., Johnson, Z., van der Veen, L., Lahn, M., Vezzelli, A., Cardin, R., Greco, A., Breda, M.
Publikováno v:
In Journal of Pharmaceutical and Biomedical Analysis 5 August 2022 217
Publikováno v:
In Journal of Pharmaceutical and Biomedical Analysis 10 September 2019 174:655-662
Autor:
Franzoni, S., Vezzelli, A., Turtoro, A., Solazzo, L., Greco, A., Tassone, P., Di Martino, M.T., Breda, M.
Publikováno v:
In Journal of Pharmaceutical and Biomedical Analysis 20 February 2018 150:300-307
Autor:
M. Mameli, J. Franchi, G. Calusi, M.A. Deken, Z. Johnson, L. van der Veen, M. Lahn, A. Vezzelli, R. Cardin, A. Greco, M. Breda
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 217
IOA-289 is a novel small molecule inhibitor of autotaxin developed as a first-in-class therapy of fibrotic pathologies including cancer. A method for quantitation of IOA-289 in human plasma was developed using a stable isotope labeled compound ([
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a2b80784474557ee7db23a7500581e2
https://pubmed.ncbi.nlm.nih.gov/35636006
https://pubmed.ncbi.nlm.nih.gov/35636006
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3546125fc65b01101a66e1a315bca9ec
https://doi.org/10.2139/ssrn.4224089
https://doi.org/10.2139/ssrn.4224089
Autor:
Luca Rigamonti, Kathryn G. Leslie, Stefano Stagni, Denis Jacquemin, Alysia Hubbard, Elizabeth Watkin, Mark I. Ogden, Anna Maria Ranieri, Haibo Jiang, Song Huang, Massimiliano Massi, Matteo Vezzelli, Elizabeth J. New
There is a lack of molecular probes for imaging bacteria, in comparison to the array of such tools available for the imaging of mammalian cells. Here, organometallic molecular probes have been developed and assessed for bacterial imaging, designed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7c1e308d519bfc0a430d42800f67cf1
https://hdl.handle.net/11380/1247549
https://hdl.handle.net/11380/1247549
Autor:
Arzu, G.D., De Ruvo, N., Montalti, R., Masetti, M., Begliomini, B., Di Benedetto, F., Rompianesi, G., Di Sandro, S., Smerieri, N., D'Amico, G., Vezzelli, E., Iemmolo, R.M., Romano, A., Ballarin, R., Guerrini, G.P., De Blasiis, M.G., Spaggiari, M., Gerunda, G.E.
Publikováno v:
In Transplantation Proceedings 2008 40(6):1937-1940
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Alberto Vezzelli, William W. Hope, Adam Belley, Shampa Das, Aaron Dane, Mameli Massimiliano, Nicola Farrington, Laura McEntee, Adam Johnson, Philipp Knechtle, Samantha Franzoni, George L. Drusano, Ruwanthi Kolamunnage-Dona
Publikováno v:
Antimicrobial Agents and Chemotherapy. 64
Klebsiella pneumoniae strains that produce extended-spectrum beta lactamases (ESBLs) are a persistent public health threat. There are relatively few therapeutic options, and there is undue reliance on carbapenems. Alternative therapeutic options are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b72d1ba17e4cb00d4d1c45dc3190a197
https://doi.org/10.1128/aac.00180-20
https://doi.org/10.1128/aac.00180-20